Search
for
Sort by
Research 391–420 of 1000+
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Adverse health effects of androgen use
- A missing piece: the spiny mouse and the puzzle of menstruating species
- Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients
- Hormone therapy in acne
- Alterations in androgen conjugate levels in women and men with alopecia
- Male hormonal contraception: looking back and moving forward
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
- Androgenetic alopecia; drug safety and therapeutic strategies
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study
- A Holistic Approach to Antiaging as an Adjunct to Antiaging Procedures: A Review of the Literature
- Genetic basis of polycystic ovary syndrome
- Chapter 17. Selective androgen receptor modulators (SARMs)
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Congenital adrenal hyperplasia
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Hormonal regulation in male androgenetic alopecia—Sex hormones and beyond: Evidence from recent genetic studies
- Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris
- Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Is there a therapeutic effect of botulinum toxin on scalp alopecia? Physiopathology and reported cases: A systematic review of the literature
- Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice
- Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome
- Ethinylestradiol/Chlormadinone Acetate